Heat shock protein 90 inhibition sensitizes acute myelogenous leukemia cells to cytarabine
Open Access
- 1 July 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 106 (1), 318-327
- https://doi.org/10.1182/blood-2004-09-3523
Abstract
Previous studies demonstrated that ataxia telangiectasia mutated– and Rad3-related (ATR) kinase and its downstream target checkpoint kinase 1 (Chk1) facilitate survival of cells treated with nucleoside analogs and other replication inhibitors. Recent results also demonstrated that Chk1 is depleted when cells are treated with heat shock protein 90 (Hsp90) inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG). The present study examined the effects of 17-AAG and its major metabolite, 17-aminogeldanamycin (17-AG), on Chk1 levels and cellular responses to cytarabine in human acute myelogenous leukemia (AML) cell lines and clinical isolates. Cytarabine, at concentrations as low as 30 nM, caused activating phosphorylation of Chk1, loss of the phosphatase Cdc25A, and S-phase slowing. Conversely, treatment with 100 to 300 nM 17-AAG for 24 hours caused Chk1 depletion that was accompanied by diminished cytarabine-induced S-phase accumulation, decreased Cdc25A degradation, and enhanced cytotoxicity as measured by inhibition of colony formation and induction of apoptosis. Additional studies demonstrated that small inhibitory RNA (siRNA) depletion of Chk1 also sensitized cells to cytarabine, whereas disruption of the phosphatidylinositol 3-kinase (PI3k) signaling pathway, which is also blocked by Hsp90 inhibition, did not. Collectively, these results suggest that treatment with 17-AAG might represent a means of reversing checkpoint-mediated cytarabine resistance in AML.Keywords
This publication has 109 references indexed in Scilit:
- G2 damage checkpoints: what is the turn-on?Journal of Cell Science, 2005
- Central Role of Fas-associated Death Domain Protein in Apoptosis Induction by the Mitogen-activated Protein Kinase Kinase Inhibitor CI-1040 (PD184352) in Acute Lymphocytic Leukemia Cells in VitroPublished by Elsevier BV ,2003
- FLT3: ITDoes matter in leukemiaLeukemia, 2003
- Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 FunctionPublished by Elsevier BV ,2002
- Inhibition of Cyclin-Dependent Kinase 2 by the Chk1-Cdc25A Pathway during the S-Phase Checkpoint Activated by Fludarabine: Dysregulation by 7-HydroxystaurosporineMolecular Pharmacology, 2002
- Inhibition of Nucleoside Transport by p38 MAPK InhibitorsPublished by Elsevier BV ,2002
- Activation of mammalian Chk1 during DNA replication arrestThe Journal of cell biology, 2001
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Proliferative Activity of Blast Cells in Leukemia and MyelofibrosisActa Medica Scandinavica, 1965
- Comparison of the Proliferative Capacity of Acute Leukæmia Cells in Bone Marrow and BloodNature, 1962